A Short Appraisal of polylactic-co-glycolic Acid Based Polymer Nanotechnology for Colon Cancer: Recent Advances and Literature Evidences

References

• Wahab S , AlshahraniMY, AhmadMF, AbbasH. Current trends and future perspectives of nanomedicine for the management of colon cancer. Eur. J. Pharmacol.910, 174464 (2021).
   PubMed Web of Science ®Google Scholar
• Sung H , FerlayJ, SiegelRLet al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin.71(3), 209–249 (2021).
   PubMed Web of Science ®Google Scholar
• Danhier F , AnsorenaE, SilvaJM, CocoR, LeBreton A, PréatV. PLGA-based nanoparticles: an overview of biomedical applications. J. Control Rel.161(2), 505–522 (2012).
   PubMed Web of Science ®Google Scholar
• Tabatabaei Mirakabad FS , Nejati-KoshkiK, AkbarzadehA, YamchiMR, MilaniM, ZarghamiNet al. PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac. J. Cancer Prev.15(2), 517–535 (2014).
   PubMedGoogle Scholar
• Lee Lee SH , BajracharyaR, MinJY, HanJW, ParkBJ, HanHK. Strategic approaches for colon targeted drug delivery: an overview of recent advancements. Pharmaceutics15(1), 68–82 (2020).
   Google Scholar
• Terzić J , GrivennikovS, KarinE, KarinM. Inflammation and colon cancer. Gastroenterology138(6), 2101–2114 (2010).
   PubMed Web of Science ®Google Scholar
• Kabir SI , KabirSA, RichardsR, AhmedJ, MacFieJ. Pathophysiology, clinical presentation and management of diversion colitis: a review of current literature. Int. J. Surg.12(5), 1088–1092 (2019).
   Google Scholar
• Wang LH , WuCF, RajasekaranN, ShinYK. Loss of tumor suppressor gene function in human cancer: an overview. Cell Physiol. Biochem.51(6), 2647–2693 (2018).
   PubMedGoogle Scholar
• Colorectal cancer stages (American Chemical Society). www.cancer.gov/types/colorectal/hp/colon-treatment-pdq ( Assessed on 10th April 2023).
   Google Scholar
• Colorectal Stages and Diagnosis. www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/staged.html ( Assessed on 10th April 2023).
   Google Scholar
• Mehta A , PatelBM. Therapeutic opportunities in colon cancer: focus on phosphodiesterase inhibitors. Life Sci.230(0), 150–161 (2019).
   PubMedGoogle Scholar
• Kaur V , SinghAS, KaurK, RathG. Targeted based drug delivery system for colon cancer. J. Drug Deliv. Ther.10(1), 111–122 (2020).
   Google Scholar
• Banerjee A , PathakS, SubramaniumVD, DharanivasanG, MurugesanR, VermaRS. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives. Drug Discov. Today22(8), 1224–1232 (2017).
   PubMed Web of Science ®Google Scholar
• Xie YH , ChenYX, FangJY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct. Target. Ther.5(1), 22 (2020).
   PubMed Web of Science ®Google Scholar
• Ganesh K , StadlerZK, CercekAet al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat. Rev. Gastroenterol. Hepatol.16(6), 361–375 (2019).
   PubMed Web of Science ®Google Scholar
• Golshani G , ZhangY. Advances in immunotherapy for colorectal cancer: a review. Ther. Adv. Gastroenterol.13, 1756284820917527 (2020).
   Web of Science ®Google Scholar
• Kim JH . Chemotherapy for colorectal cancer in the elderly. World J. Gastroenterol.21(17), 5158–5158 (2015).
   PubMed Web of Science ®Google Scholar
• Braun MS , SeymourMT. Balancing the efficacy and toxicity of chemotherapy in colorectal cancer. Ther. Adv. Med. Oncol.3(1), 43–52 (2011).
   PubMedGoogle Scholar
• Haraldsdottir S , EinarsdottirHM, SmaradottirA, GunnlaugssonA, HalfdanarsonTR. Colorectal cancer review. Laeknabladid100(2), 75–82 (2014).
   PubMed Web of Science ®Google Scholar
• Haddock MG . Intraoperative radiation therapy for colon and rectal cancers: a clinical review. Radiat. Oncol.12(1), 1–8 (2017).
   PubMedGoogle Scholar
• Biondi A , VacanteM, AmbrosinoI, CristaldiE, PietrapertosaG, BasileF. Role of surgery for colorectal cancer in the elderly. World J. Gastrointest. Surg.8(9), 606 (2016).
   PubMedGoogle Scholar
• Akgül Ö , ÇetinkayaE, ErsözŞ, TezM. Role of surgery in colorectal cancer liver metastases. World J. Gastroenterol.20(20), 6113 (2014).
   PubMed Web of Science ®Google Scholar
• Xie YH , ChenYX, FangJY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct. Target. Ther.5(1), 22 (2020).
   PubMed Web of Science ®Google Scholar
• Seeber A , GastlG. Targeted therapy of colorectal cancer. Oncol. Res. Treat.39(12), 796–802 (2016).
   PubMed Web of Science ®Google Scholar
• Singh D , KhanMA, SiddiqueHR. PLGA-based nanoparticles for the treatment of inflammatory diseases. In: Poly (Lactic-Co-glycolic Acid) (PLGA) Nanoparticles for Drug Delivery.Elsevier, Amsterdam, The Netherlands, 211–233 (2023).
   Google Scholar
• Khan FA , AlbalawiR, PottooFH. Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment. Med. Res. Rev.42(1), 227–258 (2022).
   PubMed Web of Science ®Google Scholar
• You X , KangY, HollettGet al. Polymeric nanoparticles for colon cancer therapy: overview and perspectives. J. Mater. Chem.48(19), 7779–7792 (2016).
   Google Scholar
• Alvi M , YaqoobA, RehmanK, ShoaibSM, AkashMS. PLGA-based nanoparticles for the treatment of cancer: current strategies and perspectives. AAPS Open8(1), 1–7 (2022).
   PubMedGoogle Scholar
• Tabatabaei Mirakabad FS , Nejati-KoshkiK, AkbarzadehAet al. PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac. J. Cancer Prev.15(2), 517–535 (2014).
   PubMedGoogle Scholar
• Song XR , CaiZ, ZhengY, HeG, CuiFY, GongDQet al. Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. Eur. J. Pharm. Sci.37(3-4), 300–305 (2009).
   PubMed Web of Science ®Google Scholar
• Zumaya AL , RimpelováS, ŠtějdířováM, UlbrichP, VilčákováJ, HassounaF. Antibody conjugated PLGA nanocarriers and superparamagnetic nanoparticles for targeted delivery of oxaliplatin to cells from colorectal carcinoma. Int. J. Mol. Sci.23(3), 1200 (2022).
   PubMed Web of Science ®Google Scholar
• Araújo J , VegaE, LopesC, EgeaMA, GarciaML, SoutoEB. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf. B Biointerfaces72(1), 48–56 (2009).
   PubMed Web of Science ®Google Scholar
• Houchin ML , ToppEM. Physical properties of PLGA films during polymer degradation. J. Appl. Polym. Sci.114(5), 2848–2854 (2009).
   Web of Science ®Google Scholar
• Vandervoort J , YonchevaK, LudwigA. Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles. Chem. Pharm. Bull.52(11), 1273–1279 (2004).
   PubMed Web of Science ®Google Scholar
• Wan B , AndhariyaJV, BaoQ, WangY, ZouY, BurgessDJ. Effect of polymer source on in vitro drug release from PLGA microspheres. Int. J. Pharm.607(120907), 1297–1315 (2021).
   Google Scholar
• Habraken WJ , WolkeJG, MikosAG, JansenJA. Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J. Biomater. Sci. Polym. Ed.17(9), 1057–1074 (2006).
   PubMed Web of Science ®Google Scholar
• Lanao RP , JonkerAM, WolkeJG, JansenJA, van HestJC, LeeuwenburghSC. Physicochemical properties and applications of poly (lactic-co-glycolic acid) for use in bone regeneration. Tissue Eng. Part B: Rev.19(4), 380–390 (2013).
   PubMed Web of Science ®Google Scholar
• Kapoor DN , BhatiaA, KaurR, SharmaR, KaurG, DhawanS. PLGA: a unique polymer for drug delivery. Ther. Deliv.6(1), 41–58 (2015).
   PubMed Web of Science ®Google Scholar
• Abbasnezhad N , ZirakN, ShirinbayanM, TcharkhtchiA, BakirF. On the importance of physical and mechanical properties of PLGA films during drug release. J. Drug Deliv. Sci. Technol.63, 102446 (2021).
   Web of Science ®Google Scholar
• Lotfi-Attari J , Pilehvar-SoltanahmadiY, DadashpourMet al. Co-delivery of curcumin and chrysin by polymeric nanoparticles inhibits synergistically growth and hTERT gene expression in human colorectal cancer cells. Nutr. Cancer69(8), 1290–1299 (2017).
   PubMed Web of Science ®Google Scholar
• Klippstein R , WangJT, El-GogaryRIet al. Passively targeted curcumin-loaded pegylated PLGA nanocapsules for colon cancer therapy in vivo. Small.36(36), 4704–4722 (2015).
   Google Scholar
• Wu P , ZhouQ, ZhuH, ZhuangY, BaoJ. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. BMC Cancer20(1-0), 1–10 (2020).
   Web of Science ®Google Scholar
• Chatterjee M , ChandaN. Formulation of PLGA nano-carriers: specialized modification for cancer therapeutic applications. Mater. Adv.3(2), 837–858 (2022).
   Google Scholar
• Mostafa MM , AminMM, ZakariaMY, HusseinMA, ShamaaMM, AbdEl-Halim SM. Chitosan Surface-Modified PLGA Nanoparticles Loaded with Cranberry Powder Extract as a Potential Oral Delivery Platform for Targeting Colon Cancer Cells. Pharmaceutics15(2), 606–606 (2023).
   PubMed Web of Science ®Google Scholar
• Zhang D , LiuL, WangJet al. Drug-loaded PEG-PLGA nanoparticles for cancer treatment. Front. Pharmacol.13, 990505 (2022).
   PubMed Web of Science ®Google Scholar
• Esmaeili F , GhahremaniMH, EsmaeiliB, KhoshayandMR, AtyabiF, DinarvandR. PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. Int. J. Pharm.349(1-2), 249–255 (2008).
   PubMedGoogle Scholar
• Lvi M , YaqoobA, RehmanK, ShoaibSM, AkashMS. PLGA-based nanoparticles for the treatment of cancer: current strategies and perspectives. AAPS Open8(1), 1–11 (2022).
   PubMedGoogle Scholar
• Ozturk K , CabanS, KozluS, KadayifciE, YerlikayaFI, CapanYI. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles. Pharmazie65(9), 665–669 (2010).
   PubMed Web of Science ®Google Scholar
• Razavi MS , AbdollahiA, Malek-KhatabiAet al. Recent advances in PLGA-based nanofibers as anticancer drug delivery systems. J. Drug Deliv. Sci. Technol.85, 104587 (2023).
   Web of Science ®Google Scholar
• Waghela BN , SharmaA, DhumaleS, PandeySM, PathakC. Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cells. PLOS ONE10(2), e0117526 (2015).
   PubMed Web of Science ®Google Scholar
• Mohammadi G , ValizadehH, Barzegar-JalaliMet al. Development of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi. Colloids Surf B Biointerfaces80(1), 34–39 (2010).
   PubMed Web of Science ®Google Scholar
• Ünal S , DoğanO, AktaşY. Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics. Beilstein J. Nanotechnol.13(1), 1393–1407 (2022).
   PubMedGoogle Scholar
• Ghasemi Toudeshkchouei M , ZahediP, ShavandiA. Microfluidic-assisted preparation of 5-fluorouracil-loaded PLGA nanoparticles as a potential system for colorectal cancer therapy. Materials13(7), 1483 (2010).
   Google Scholar
• Li L , LiC, ZhouJ. Effective sustained release of 5-FU-loaded PLGA implant for improving therapeutic index of 5-FU in colon tumor. Int. J. Pharm.550(1-2), 380–387 (2018).
   PubMedGoogle Scholar
• Khaledi S , JafariS, HamidiS, MolaviO, DavaranS. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin. J. Biomater. Sci. Polym. Ed.31(9), 1107–1126 (2020).
   PubMed Web of Science ®Google Scholar
• Wu P , ZhouQ, ZhuH, ZhuangY, BaoJ. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. BMC Cancer20, 1–10 (2020).
   Web of Science ®Google Scholar
• Nandagiri VK , GentileP, ChionoVet al. Incorporation of PLGA nanoparticles into porous chitosan-gelatin scaffolds: influence on the physical properties and cell behavior. J. Mech. Behav. Biomed. Mater.4(7), 1318–1327 (2011).
   PubMed Web of Science ®Google Scholar
• Emami J , MaghziP, HasanzadehF, SadeghiH, MirianM, RostamiM. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan. Pharm. Dev. Technol.23(1), 41–54 (2018).
   PubMed Web of Science ®Google Scholar
• Saraf A , DubeyN, DubeyN, SharmaM. Enhancement of cytotoxicity of diallyl disulfide toward colon cancer by Eudragit S100/PLGA nanoparticles. J. Drug Deliv. Sci. Technol.64, 102580 (2021).
   Web of Science ®Google Scholar
• Lin B , XuX, ZhangX, YuY, WangX. Photodynamic Treatment of Colorectal Cancer Using Chlorin e6-Loaded Poly (lactide-co-glycolide)-Based Nanoparticles. J. Biomed. Nanotechnol.17(10), 1939–1950 (2021).
   PubMed Web of Science ®Google Scholar
• Rahmati A , HomayouniTabrizi M, KarimiE, ZareiB. Fabrication and assessment of folic acid conjugated-chitosan modified PLGA nanoparticle for delivery of alpha terpineol in colon cancer. J. Biomater. Sci. Polym. Ed.33(10), 1289–1307 (2022).
   PubMed Web of Science ®Google Scholar
• He P , XuS, GuoZet al. Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy. Drug Deliv.29(1), 478–488 (2022).
   PubMed Web of Science ®Google Scholar
• Anwer MK , AliEA, IqbalMet al. Development of Chitosan-Coated PLGA-Based Nanoparticles for Improved Oral Olaparib Delivery: in Vitro Characterization, and In Vivo Pharmacokinetic Studies. Processes10(7), 1329 (2022).
   Web of Science ®Google Scholar
• Chandra Boinpelly V , VermaRK, SrivastavS, SrivastavaRK, ShankarS. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway. J. Cell Mol. Med.19(11), 11343–1154 (2020).
   Google Scholar
• de SL Oliveira ALC , AraújoJúnior RF, Gomesde Carvalho Tet al. Effect of oxaliplatin-loaded poly(d,l-lactide-co-glycolic acid) (PLGA) nanoparticles combined with retinoic acid and cholesterol on apoptosis, drug resistance, and metastasis factors of colorectal cancer. Pharmaceutics12(2), 193 (2020).
   PubMed Web of Science ®Google Scholar
• Zumaya AL , RimpelováS, ŠtějdířováM, UlbrichP, VilčákováJ, HassounaF. Antibody conjugated PLGA nanocarriers and superparamagnetic nanoparticles for targeted delivery of oxaliplatin to cells from colorectal carcinoma. Int. J. Mol. Sci.23(3), 1200 (2022).
   PubMed Web of Science ®Google Scholar
• Zhang R , JiangY, HaoLet al. Cd44/Folate Dual Targeting Receptor Reductive Response Plga-Based Micelles for Cancer Therapy. Front Pharmacol.13, 111 (2022).
   Web of Science ®Google Scholar
• Almnhawy M , JeburM, AlhajameeM, MaraiK, TabriziMH. PLGA-based nano-encapsulation of trachyspermum ammi seed essential oil (TSEO-PNP) as a safe, natural, efficient, anticancer compound in human HT-29 colon cancer cell line. Nutr. Cancer73(11-12), 2808–2820 (2021).
   PubMed Web of Science ®Google Scholar
• Alirezaei M , GhobehM, Es-haghiA. Poly(lactic-co-glycolic acid) (PLGA)-based nanoparticles modified with chitosan-folic acid for the delivery of Artemisia vulgaris L. essential oil to HT-29 cancer cells. Process Biochem.121(1), 207–215 (2022).
   Google Scholar
• Peng J , ZhouJ, SunR, ChenY, PanD, WangQet al. Dual-targeting of artesunate and chloroquine to tumor cells and tumor-associated macrophages by a biomimetic PLGA nanoparticle for colorectal cancer treatment. Int. J. Biol. Macromol.125, 163–169 (2023).
   Google Scholar
• He Y , ChenQW, YuJX, QinSY, LiuWL, MaYHet al. Yeast cell membrane-camouflaged PLGA nanoparticle platform for enhanced cancer therapy. J. Control Rel.359, 347–358 (2023).
   PubMed Web of Science ®Google Scholar